Cegedim SA (EPA:ALCGM)
France · Delayed Price · Currency is EUR 12.60
+0.35 (2.86%)
Apr 2, 2026, 5:35 PM CET
Cegedim Revenue
In the year 2025, Cegedim had annual revenue of 649.17M EUR, down -0.81%. Cegedim had revenue of 326.68M in the half year ending December 31, 2025, with 3.71% growth.
Revenue
649.17M
Revenue Growth
-0.81%
P/S Ratio
0.27
Revenue / Employee
98.29K
Employees
6,605
Market Cap
173.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 649.17M | -5.32M | -0.81% |
| Dec 31, 2024 | 654.50M | 38.50M | 6.25% |
| Dec 31, 2023 | 616.00M | 60.79M | 10.95% |
| Dec 31, 2022 | 555.21M | 30.50M | 5.81% |
| Dec 31, 2021 | 524.71M | 27.77M | 5.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.97B |
| Bastide Le Confort Médical | 510.48M |
| Eurobio Scientific Société anonyme | 162.47M |
| Cellectis | 67.79M |
| Median Technologies | 23.38M |
Cegedim News
- 7 days ago - Full Year 2025 Cegedim SA Earnings Call Transcript - GuruFocus
- 5 months ago - Half Year 2025 Cegedim SA Earnings Call Transcript - GuruFocus
- 6 months ago - Cegedim's profitability improving as expected in H1 2025 - Benzinga